Escobar Álvarez, Y. http://orcid.org/0000-0001-5492-6739
De Castro Carpeño, J.
Bell, D.
Drago, A.
Franceschetti, A.
Funding for this research was provided by:
Vifor Pharma
Helsinn
Article History
Received: 26 February 2021
Accepted: 7 April 2021
First Online: 6 May 2021
Declarations
:
: Yolanda Escobar Álvarez has received educational grants, acted as a consultant, attended advisory boards and given lectures for the following organizations: AstraZeneca, Bristol-Myers Squibb, Merck Serono, MSD, Angelini, Vifor Pharma, Kiowa Kirin, and Mylan. Javier De Castro Carpelo has received educational grants from Astra-Zeneca, Boehringer Ingelheim, BMS, MSD, Novartis and Roche, as well as scientific consulting honoraria from Astra-Zeneca, Boehringer Ingelheim, BMS, MSD, Novartis, Pfizer, Roche and Takeda. Danielle Bell, Anthony Drago and Alessandra Franceschetti were full-time employees of Ipsos Healthcare at the time the study was conducted.
: This article does not contain any studies with human participants or animal performed by any of the authors.
: For this type of study formal consent is not required.